Blog

RSS Feed
Posted by Michael Wonder on 12 Jul 2018

ICER releases draft evidence report on anti-androgen therapies for non-metastatic castration-resistant prostate cancer

12 July 2018 - Public comment period now open until 9 August; requests to make oral comment during public meeting also ...

Read more →
Posted by Michael Wonder on 01 Jun 2018

New analysis shows using ICER’s value assessments would limit access to life-saving medicines in Medicare Part B

31 May 2018 - 62 to 93% of Medicare Part B beneficiaries with serious, complex conditions could lose access to their ...

Read more →
Posted by Michael Wonder on 07 May 2017

Institute for Clinical and Economic Review's draft evidence report on abuse-deterrent opioids evaluates clinical and economic evidence on nine formulations

5 May 2017 - Public comment period now open until 2 June; requests to make oral comment during public meeting ...

Read more →
Posted by Michael Wonder on 13 Nov 2016

ICER to review drug treatments for osteoporosis in upcoming report

11 November 2016 - The ICER will develop a report assessing the comparative clinical effectiveness and value of emerging drug ...

Read more →